MabVax Therapeutics' Reverse Merger Round

MabVax Therapeutics raised a round of funding on July 09, 2014. Investors include Telik.

MabVax Therapeutics is a clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address unmet medical needs in the treatment of cancer. MabVax is cr…

Articles about MabVax Therapeutics' Reverse Merger Round: